AKOYA Bio - Logo - Standard Centered.png
Akoya to Participate at Three Upcoming Investor Conferences
November 02, 2023 08:00 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023
October 31, 2023 09:00 ET | Akoya Biosciences, Inc.
Spatial Biology 2.0 solutions enable discovery and translational workflows at an unprecedented speed and scale Global network of CROs providing Akoya’s spatial phenotyping solutions will also exhibit...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures
October 17, 2023 10:22 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that researchers from Akoya Biosciences and The...
AKOYA Bio - Logo - Standard Centered.png
Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
October 11, 2023 16:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
September 19, 2023 08:00 ET | Akoya Biosciences, Inc.
PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies.PhenoImager HT 2.0 delivers a 5x greater speed improvement for spatial studies in translational...
AKOYA Bio - Logo - Standard Centered.png
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
August 07, 2023 16:05 ET | Akoya Biosciences, Inc.
Q2 2023 revenue $23.5 million, 31% y/y growth Reiterating FY 2023 revenue guidance range of $95-98 million MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq:...
AKOYA Bio - Logo - Standard Centered.png
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
August 07, 2023 08:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The Spatial Biology Company®, today announced a momentous achievement - publication of the...
AKOYA Bio - Logo - Standard Centered.png
Akoya to Participate at Three Upcoming Investor Conferences
July 26, 2023 16:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 26, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in...
AKOYA Bio - Logo - Standard Centered.png
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
July 12, 2023 08:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
AKOYA Bio - Logo - Standard Centered.png
Akoya to Participate at Two Upcoming Investor Conferences
June 12, 2023 16:05 ET | Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in...